Biological samples degrade rapidly without a continuous cold chain. ZORIA T-37 replaces bulky, expensive cooling infrastructure with a proprietary biochemical formulation. Our medium puts pathogens into a deep, reversible metabolic stasis, providing a confirmed bacteriostatic effect for 72 hours at extreme temperatures of 37°C. Furthermore, it stabilizes eukaryotic cells (including blood cells) for over 50 hours without any refrigeration.
CAPABILITY – 72h stability for bacteria at 37°C, 50h+ for eukaryotic cells without cooling.
IMPACT – Eradication of dry ice logistics, saving over $250 per package and reducing the carbon footprint by over 2 kg of CO2 per unstable sample.
TARGET – Regional Hospitals, Global Diagnostic Hubs.
CURRENT TRL – 4
Currently, global cell cultures rely on antibiotics to protect against infections, which alters cell physiology and complicates downstream processes. We are adapting our GRAS-certified stasis technology to create a biomimetic formulation that protects eukaryotic cell cultures and biobanks without the use of antibiotics.
CAPABILITY – Synergistic protection and eventual full replacement of antibiotics in in-vitro cultures.
IMPACT – Elimination of cytotoxic effects, prevention of AMR (Antimicrobial Resistance) in industrial bioreactors.
TARGET – Deep Tech R&D Units, Industrial Biotech, Advanced Biobanking.
CURRENT TRL – 3